Sanderling Ventures
Venture capitalSan Mateo · Late Stage · 9 people tracked
Investment thesis
The firm believes that significant biomedical companies are best developed through close working partnerships between investors and entrepreneurs. Sanderling combines specialized investment focus, active management, and long-term commitment across small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, and medical devices to generate strong returns.
Source: firm website, verified Jul 21, 2026.
Team · 9 people
from the firm's website
The founder of Sanderling Ventures in 1979, McNeil served as Managing Director and was an early seed investor in multiple successful biomedical companies before his passing in 2021.
An experienced investor and operating partner with over 30 years in biotechnology and biomedical industries, Middleton has worked as an investor, management team member, and director on over 20 biomedical ventures in Sanderling's portfolio since 1988.
A venture capital and biomedical research veteran with over 25 years of experience, Mills has participated in 20+ companies across biotherapeutics, medical technology, and health IT in both investor and operating roles, joining Sanderling as an Operating Partner in 1998.
With over 40 years of experience in medical products and biotechnology across corporate management and venture capital, Wollaeger joined Sanderling in 2002 as a Managing Director and opened the firm's San Diego office.
A CPA with over 18 years in executive roles at venture-backed companies, Dixon serves as CEO of Therillia Development Company and previously held CFO positions at venture-stage biomedical firms.
A legal professional with J.D. credentials and extensive domestic and international corporate legal experience, Taylor served as Sanderling's full-time counsel from 1996 to 2015 and continues as counsel to the firm and select portfolio companies.
A pharma executive with over two decades of biotechnology experience, McGraw serves as Executive Chairman and CEO of TheraVida and was previously Chairman and CEO of Valentis, a public biotechnology company.
A biotech leader with a Ph.D. and MBA, McWilliams is currently Chief Business Officer of Glycomine and was previously a Managing Director at Sanderling overseeing investments in orphan drug development.
A biopharmaceutical executive with over 25 years in large pharma and development-stage companies, Beauparlant brings expertise in discovery through commercialization and has served as CEO of multiple Sanderling portfolio companies.
What they invest in
from 27 of 69 portfolio companiesMedical Devices ×20Biotech ×16Healthtech ×14AI & Machine Learning ×2Digital Health ×2Advanced Manufacturing ×1Circular Economy ×1Consumer ×1
HQs:United States×7France×1
Investments · showing 60 of 69
founders shown can be your intro pathUCB is a global biopharmaceutical company that develops and delivers medicines to treat neurological and autoimmune conditions. The company focuses on improving the lives of patients living with severe diseases through innovative therapeutic solutions.
Biotech<UNKNOWN>
Artielle Immunotherapeutics develops DRhQ, a therapeutic platform targeting CD74 receptors to treat neuroinflammatory conditions like progressive multiple sclerosis and advanced cancers. The company's approach blocks macrophage migration inhibitory factor signaling to redirect immune cell activity away from CNS injury sites.
AI & Machine LearningBiotechMedical DevicesPortland, US
CalciMedica is a clinical-stage biopharmaceutical company developing therapies that inhibit CRAC calcium channels to address acute and chronic inflammatory, immunologic, and cardiopulmonary diseases. The company's lead compound targets conditions including acute pancreatitis, acute kidney injury, and pulmonary arterial hypertension.
BiotechHealthtechMedical Devices
Philips provides cardiac monitoring and diagnostic solutions that connect patient monitoring across hospital and home settings. The company serves healthcare providers and patients through ECG solutions, ambulatory monitoring, and implantable device management across the cardiac care continuum.
Digital HealthHealthtechMedical Devices
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical Devices
DalCor Pharmaceuticals develops dalcetrapib, a precision medicine treatment for cardiovascular disease targeting patients with a specific genetic marker (ADCY9 AA genotype). The company is conducting clinical trials to demonstrate the drug's ability to reduce heart attacks in post-acute coronary syndrome patients.
BiotechDigital HealthMedical Devices
Skyepharma is a French contract development and manufacturing organization (CDMO) specializing in complex oral solid dosage forms, including modified-release tablets, highly potent APIs, and orphan drugs, serving pharmaceutical companies worldwide from early-stage development through commercial manufacturing.
Advanced ManufacturingBiotechMedical DevicesFrance, FR
DePuy Synthes develops orthopedic medical devices and solutions including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine products, along with digital surgery technologies. The company serves surgeons and healthcare institutions performing orthopedic procedures.
HealthtechMedical Devices
Digirad manufactures portable nuclear medicine imaging cameras for cardiology and general nuclear imaging applications. The company designs general-purpose SPECT/FAC imaging devices with emphasis on image quality and ease of use.
HardwareMedical Devices
Dynavax is a biopharmaceutical company that develops and commercializes novel vaccines using adjuvant technology to protect against infectious diseases. The company focuses on vaccine development for protection against various infectious disease threats.
Biotech
BiotechMedical Devices
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options. The company focuses on addressing unmet medical needs in the rare disease space.
Biotech
Steven Axon(Chief Executive Officer)Hicham Alaoui(Chief Scientific Officer)Rose Marino(Chief Medical Officer)Peter McWilliams(Chief Business Officer)
Makoto is an intravascular imaging platform that combines high-resolution structural visualization with plaque compositional analysis for vascular treatment guidance.
Medical Devices
Bionano Genomics develops optical genome mapping (OGM) systems, software, and analysis tools for detecting structural variants and chromosomal aberrations in genomic samples. The company serves clinical laboratories, research institutions, and therapeutic companies working on cancer diagnosis, genetic disease detection, and cell therapy quality control.
BiotechDeep TechMedical Devices
Metavention develops a treatment that targets the sympathetic nervous system to address high blood pressure and metabolic diseases using neuromodulation technology.
Medical Devices
CMR Naviscan develops medical imaging technology for breast cancer detection that aims to improve detection rates and reduce unnecessary biopsies in women with dense breast tissue.
Medical Devices
Pacira develops non-opioid therapies and advanced treatments for musculoskeletal and chronic pain management, including gene therapy research. The company serves patients requiring pain management solutions and aims to reduce reliance on opioid-based treatments.
BiotechHealthtechMedical Devices
Regeneron discovers, develops, and manufactures biologics and genetic medicines for treating serious diseases including metabolic disorders, ophthalmology conditions, and rare diseases. The company serves patients globally through clinical trials and commercial pharmaceutical products.
BiotechHealthtechMedical DevicesTarrytown, US
Abbott is a diversified healthcare company that manufactures cardiovascular devices and therapies for treating conditions like atrial fibrillation and heart failure. The company serves healthcare professionals and patients through a portfolio of cardiac and vascular solutions supported by clinical evidence.
HealthtechMedical DevicesAbbott Park, US
Sotera Wireless manufactures the ViSi Mobile System, a wearable patient monitoring platform that continuously tracks vital signs including blood pressure, oxygen saturation, heart rate, and ECG in general hospital care settings. The system uses machine learning to detect patient deterioration early and integrates with electronic medical records to improve clinical workflows.
AI & Machine LearningHealthtechMedical Devices
Philips develops health and sustainability-focused consumer products and applications designed for durability and recycling. The company serves individuals and families seeking healthier lifestyles through technology solutions aligned with circular economy principles.
Circular EconomyConsumerHealthtech
Stereotaxis develops robotic systems for endovascular and cardiac ablation procedures in interventional medicine. The company serves hospitals and physicians performing minimally invasive interventions.
HealthtechMedical DevicesRoboticsSaint Louis, US
TheraVida is a clinical-stage pharmaceutical company developing therapies for hyperhidrosis, a condition characterized by excessive sweating. The company's lead product, Anhydrix™, combines multiple drugs with improved tolerability and has completed phase 2 clinical trials.
BiotechHealthtechChapel Hill, US
Takeda Pharmaceuticals is a global pharmaceutical company developing medicines and creating new standards of care for patients and communities across therapeutic areas.
BiotechHealthtech
Merck is a pharmaceutical company focused on developing medicines and vaccines for patients globally, guided by a science-led innovation strategy.
BiotechHealthtechMedical DevicesRahway, US
Frequently asked questions
- What stage does Sanderling Ventures invest at?
- Sanderling Ventures invests at the Late Stage stage.
- What sectors does Sanderling Ventures focus on?
- Sanderling Ventures focuses on Biotech, Medical Devices.
- Where is Sanderling Ventures located?
- Sanderling Ventures is headquartered in San Mateo, US.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
EQT Life Sciences is one of Europe's largest and most experienced life sciences investors, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. The firm has raised approximately 3.5 billion euros across 12 private funds and 3 investment strategies over its 30-year history.